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Author Correction: A practical guide for mutational
signature analysis in hematological malignancies
Francesco Maura1,2,3, Andrea Degasperi 3,4,5, Ferran Nadeu 6,7, Daniel Leongamornlert3, Helen Davies3,4,5,
Luiza Moore 3, Romina Royo8, Bachisio Ziccheddu9, Xose S. Puente 10,11, Herve Avet-Loiseau12,
Peter J. Campbell3, Serena Nik-Zainal3,4,5, Elias Campo6,7,8, Nikhil Munshi13,14 & Niccolò Bolli2,9
Correction to: Nature Communications https://doi.org/10.1038/s41467-019-11037-8, published online 5 July 2019.
The original version of this Article contained an error in the spelling of the author Peter J Campbell, which was incorrectly given as
Peter J Cambell. This has now been corrected in both the PDF and HTML versions of the Article.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
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